Second annual IBS Pharma customer forum votes standardization issue most important

Second annual IBS Pharma customer forum votes standardization issue most
important 

Participants at the 2nd IBS Pharma GSE conference discussed current and upcoming
challenges faced by pharmaceutical wholesale distributors

STOCKHOLM, November 20, 2009 - International Business Systems (STO: IBS B) the
leading application supplier for wholesale and distribution, today publishes a
report from the second annual IBS Pharma customer forum held in Hamburg earlier
this quarter. The user group was held in Munich and focused on communication and
information exchange throughout the pharmaceutical supply chain, with keynote
speeches from Monika Derecque-Pois, Director General at GIRP (Groupement
International de la Répartition Pharmaceutique Européenne), Gerald Lassau,
Director Software Solution at Knapp AG, Andreas Varesi, Managing Director of
Technomar and Andy Bailey, Chief Marketing Officer at IBS AB. 

“What was especially important for me today was our host's public commitment to
the long-term development of IBS Pharma for the German market”, said
Karl-Heinrich Meyer, Managing Director at C. Krieger & Co. Nachfolger GmbH & Co.
KG, Koblenz. “Among all the consistently interesting presentations I was
particularly fascinated by the one given by the Italian corporate user Ragusa
Remo Farmaceutici: they are active in additional business areas that are not
part of pharmaceutical wholesale in Germany, for example parallel imports. And
yet they cover all that with one and the same industry-specific solution which
is IBS Pharma."

"These days the power lies on the demand side, and not with the provider", said
IBS Global Chief Marketing Officer Andy Bailey. "This shift in the industry
means that distribution has become an important competitive factor in an
industry that needs to overcome particular challenges."

For a full report of the conference you can download it as a White Paper from
http://www.ibs.net (English version) or a German version from
http://www.ibs.net/de  

 
For more information, please contact:
Oskar Ahlberg, Senior Vice President of Communications, IBS AB
Tel: +46-70-244 24 75
oskar.ahlberg@ibs.net


German press contact:
ars publicandi GmbH
Martina Overmann
Schulstraße 28
D-66976 Rodalben
Tel.: +49/6331/5543-13, Fax: -43

MOvermann@ars-pr.de
www.ars-pr.de
Author: Andreas Becker 


About IBS
IBS specialises in differentiating companies from their competitors on the
strength of their distribution operations. 
Founded in 1978, IBS has over 30 year's experience of distribution in industries
ranging from automotive and electronics to paper, publishing and
pharmaceuticals. This deep understanding of distribution models and best
practices is embodied in IBS' global distribution system, which is enhanced with
local expertise to create a unique system for each IBS client. 

More than 4,000 companies in 40 countries rely on IBS to improve their
distribution operations - enabling them to achieve both increased profitability
and higher valued services to the channel.
IBS B share is listed on NASDAQ OMX First North Exchange Stockholm. For more
information, please visit www.ibs.net

About Leopold Fiebig 
Leopold Fiebig GmbH & Co. KG, headquartered in Rheinstetten, is an independent,
privately run full-line distributor with a history of more than 100 years. The
85 employees of the medium-sized pharmaceutical wholesaler provide pharmacies in
Southwestern Germany with prescription medicine, OTC drugs and various lifestyle
products. The company covers an area stretching from Idar-Oberstein to Müllheim,
from Primasens to Schwäbisch Hall. In their state-of-the-art logistics centre,
where some 80,000 items are continuously in stock, Fiebig reaches an automation
degree of 90% in the logistics area. As a result, up to 2,400 orders can be
processed per hour, with a maximum throughput time of just 15 minutes from
receipt of order to loading of goods. Please refer to http://www.fiebig.de for
more information.